Comparison Overview
This is CGT

This is CGT
N/A
Last Update: 01/03/2026
This is an innovation in disease treatment. This is Cell and Gene Therapy (CGT). Learn more about covering CGTs in benefits plans at ThisIsCGT.com © Johnson & Johnson and its affiliates 2025 02/25 cp-497508v1

Novartis
Novartis Campus, Basel, 4002, CH
Last Update: 04/08/2026
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million pe...
Compliance Ranges Comparison

This is CGT







Novartis






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for This is CGT in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Novartis has 2.91% fewer incidents than the average of all companies with at least one recorded incident.
Incident History - This is CGT (X = Date, Y = Severity)
This is CGT cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Novartis (X = Date, Y = Severity)
Novartis cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

This is CGT

Novartis
FAQ
Latest Global CVEs
An issue in the SBN UDP interface of NASA cFS v7.0.1 allows attackers to cause a Denial of Service (DoS) via transmitting a crafted SBN frame.
A stack-based buffer overflow vulnerability exists in the cmd_edl function of OreSat Firmware v1.0. The vulnerability is triggered when processing the edl fw_flash command, where the <filename> argument is copied to a 64-byte stack buffer via memcpy without proper length validation. An attacker with physical access to the UART3 serial interface can exploit this vulnerability by sending a maliciously crafted command with an oversized filename parameter,
Adobe Campaign Classic (ACC) is affected by a Violation of Secure Design Principles vulnerability that could result in a Security feature bypass. An attacker could leverage this vulnerability to bypass security measures and gain unauthorized read access. Exploitation of this issue does not require user interaction.
Adobe Campaign Classic (ACC) is affected by an Incorrect Authorization vulnerability that could result in privilege escalation. An attacker could exploit this vulnerability to gain elevated privileges. Exploitation of this issue does not require user interaction.
Adobe Campaign Classic (ACC) is affected by a Server-Side Request Forgery (SSRF) vulnerability that could result in privilege escalation. Exploitation of this issue does not require user interaction. Scope is changed.